NYSE: PFEPfizer Inc Earnings & Revenue
PFE past earnings growth
How has PFE's earnings growth performed historically?
Company
13.84%
Industry
10.68%
Market
82.89%
PFE's earnings have grown faster (12.26% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
PFE's earnings have grown slower (12.26% per year) than the US market average (77.34%)
Performance
PFE's earnings growth is accelerating - its growth over the last year (13.84%) is above its 5-year compound annual rate (12.26%)
Performance
PFE past revenue growth
How has PFE's revenue growth performed historically?
Company
-8.31%
Industry
6.62%
Market
16.55%
PFE's revenue has grown slower (0.41% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
PFE's revenue has grown slower (0.41% per year) than the US market average (15.67%)
Performance
PFE's revenue growth is slowing down - its growth over the last year (-8.31%) is below its 5-year compound annual rate (0.41%)
Performance
PFE earnings and revenue history
Current Revenue
$49.2B
Current Earnings
$14.2B
Current Profit Margin
28.80%
PFE's has demonstrated consistent long-term earnings growth over the past 10 years (142.86%)
Performance
PFE Return on equity
Current Company
22.00%
Current Industry
10.90%
Current Market
-36.30%
PFE's Return on Equity (22.00%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance
PFE Return on assets
Current Company
8.30%
Current Industry
8.50%
Current Market
6.20%
PFE is generating higher Return on Assets (8.30%) than the US Drug Manufacturers - General industry average (8.27%)
Performance
PFE Return on capital employed
Current Company
11.73%
Current Industry
12.80%
PFE has gotten more efficient at generating Return on Capital (11.73%) compared to 3 years ago (7.18%)
Performance
PFE earnings dates
- Next earnings date
- Oct 27, 2020
Pfizer Earnings & Revenue FAQ
What were PFE's earnings last quarter?
On Apr 28, 2020, Pfizer (NYSE: PFE) reported Q1 2020 earnings per share (EPS) of $0.61, up 11.59% year over year. Total Pfizer earnings for the quarter were $3.40 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.69.
What was PFE's revenue last quarter?
On Apr 28, 2020, Pfizer (NYSE: PFE) reported Q1 2020 revenue of $12.03 billion up 8.31% year over year. In the same quarter last year, Pfizer's revenue was $13.12 billion.
What was PFE's earnings growth in the past year?
As of Q4 2020, Pfizer's earnings has grown 13.84% year over year. This is 3.16 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. Pfizer's earnings in the past year totalled $14.17 billion.
What was PFE's revenue growth in the past year?
As of Q4 2020, Pfizer's revenue has grown -8.31% year over year. This is 14.93 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. Pfizer's revenue in the past year totalled $49.20 billion.
What is PFE's earnings date?
Pfizer's earnings date is Oct 27, 2020. Add PFE to your watchlist to be reminded of PFE's next earnings announcement.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
